Relay Therapeutics, Inc. (RLAY)
20.39
+1.79
(+9.62%)
USD |
NASDAQ |
Nov 09, 16:00
20.05
-0.34
(-1.67%)
Pre-Market: 09:21
Relay Therapeutics Cash and Short Term Investments (Quarterly) : 848.64M for Sept. 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 848.64M |
| June 30, 2026 | 910.93M |
| March 31, 2026 | 642.06M |
| December 31, 2025 | 554.52M |
| September 30, 2025 | 596.43M |
| June 30, 2025 | 656.78M |
| March 31, 2025 | 710.36M |
| December 31, 2024 | 781.32M |
| September 30, 2024 | 839.61M |
| June 30, 2024 | 688.42M |
| March 31, 2024 | 749.61M |
| December 31, 2023 | 750.09M |
| September 30, 2023 | 810.62M |
| June 30, 2023 | 871.57M |
| Date | Value |
|---|---|
| March 31, 2023 | 937.80M |
| December 31, 2022 | 998.92M |
| September 30, 2022 | 1.054B |
| June 30, 2022 | 837.99M |
| March 31, 2022 | 898.18M |
| December 31, 2021 | 958.07M |
| September 30, 2021 | 616.51M |
| June 30, 2021 | 671.22M |
| March 31, 2021 | 726.08M |
| December 31, 2020 | 678.06M |
| September 30, 2020 | 713.47M |
| June 30, 2020 | 312.21M |
| March 31, 2020 | 334.20M |
| December 31, 2019 | 355.82M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| SELLAS Life Sciences Group, Inc. | 138.44M |
| TG Therapeutics, Inc. | 556.71M |
| Spyre Therapeutics, Inc. | 1.072B |
| ACADIA Pharmaceuticals, Inc. | 976.45M |
| Alnylam Pharmaceuticals, Inc. | 3.587B |